Results 211 to 220 of about 449,109 (258)

Acute and chronic impact of interleukin-33 stimulation on chemokines and growth factors in human cord blood-derived mast cells. [PDF]

PLoS One
Bakhashab S, Banafea GH, Ahmed F, Alsolami R, Schulten HJ, Gauthaman K, Naseer MI, Pushparaj PN.   +7 more
europepmc   +1 more source

Interleukin-33 links asthma to alopecia areata: Mendelian randomization and mediation analysis.

Skin Res Technol
Wu P, Tian K, Gao S, Jia Z, Xu W, Wang X, Wu L.   +6 more
europepmc   +1 more source

The Interleukin 33-T Helper 2 Cell Axis Promotes Human Liver Fibrosis. [PDF]

Cell Mol Gastroenterol Hepatol
Lurje I, Tacke F.
europepmc   +1 more source

Inhibition of Interleukin-33 to Reduce Glomerular Endothelial Inflammation in Diabetic Kidney Disease. [PDF]

Kidney Int Rep
Hofherr A, Liarte Marin E, Musial B, Seth A, Slidel T, Conway J, Baker D, Hansen PBL, Challis B, Bartesaghi S, Bhat M, Pecoits-Filho R, Tu X, Selvarajah V, Woollard K, Heerspink HJL.   +15 more
europepmc   +1 more source

Low Secretory Leukocyte Protease Inhibitor (SLPI)-Level Potentiates Alternaria Extract-Induced T-Helper 2 (Th2) Airway Inflammation via the Interleukin-33 (IL-33) Pathway. [PDF]

Cureus
Hirano T, Koarai A, Ohkouchi S, Sugiura H, Kurosawa H.   +4 more
europepmc   +1 more source

Circulating interleukin-33 levels in obesity and type 2 diabetes: a systematic review and meta-analysis.

Am J Physiol Endocrinol Metab
Missous G, Van Panhuys N.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Interleukin-33 in health and disease

Nature Reviews Immunology, 2016
Interleukin-33 (IL-33) - a member of the IL-1 family - was originally described as an inducer of type 2 immune responses, activating T helper 2 (TH2) cells and mast cells. Now, evidence is accumulating that IL-33 also potently stimulates group 2 innate lymphoid cells (ILC2s), regulatory T (Treg) cells, TH1 cells, CD8+ T cells and natural killer (NK ...
Foo Yew, Liew, Jean-Philippe, Girard, Heth Roderick, Turnquist   +2 more
openaire   +2 more sources

Role of interleukin 33 in human immunopathology

Annals of the Rheumatic Diseases, 2010
Interleukin 33 (IL33) is a recently described member of the IL1 superfamily of cytokines. Originally defined on the basis of T-cell subset differentiation, IL33 is now recognised to mediate a wider role in regulating components of the innate immune response also, particularly via mast cell activation.
G E J, Murphy, D, Xu, F Y, Liew, I B, McInnes   +3 more
openaire   +2 more sources

Association of serum interleukin‐33 level and the interleukin‐33 genetic variant with Japanese cedar pollinosis

Clinical & Experimental Allergy, 2008
SummaryBackground IL‐33, an IL‐1‐like cytokine, is a ligand for IL1RL1, which is an important effector molecule of type 2 T helper responses. Although IL‐33/IL1RL1 interaction has been suggested to be important in induction of allergic airway inflammation, serum levels of IL‐33 and the genetic influences of the polymorphisms of IL‐33 in human ...
M, Sakashita, T, Yoshimoto, T, Hirota, M, Harada, K, Okubo, Y, Osawa, S, Fujieda, Y, Nakamura, K, Yasuda, K, Nakanishi, M, Tamari   +10 more
openaire   +2 more sources

Interleukin-33 and Atherosclerosis

2011
Interleukin (IL)-33 (also known as IL-1 F11) is a newly identified member of the IL-1 cytokine family with close amino acid sequence homology to IL-18 [1]. The human and mouse sequences for IL-33 have been mapped to chromosomes 9 (9p24.1) and 19 (19qc1), encoding proteins of 270 and 266 amino acids respectively.
Foo Y. Liew, Ashley M. Miller
openaire   +1 more source